[The council for new therapies position on eculizumab is unacceptable].
Karpman D, Fehrman-Ekholm I, Bárány P, Békássy Z, Brandström P, Bruchfeld A, Celsi G, Chromek M, Clyne N, Fellström B, Hansson S, Haraldsson B, Nevéus T, Rippe B, Sartz L, Segelmark M, Stegmayr B, Stenvinkel P, Tufveson G, Westman K.
Karpman D, et al. Among authors: segelmark m.
Lakartidningen. 2015 Jun 9;112:DI3F.
Lakartidningen. 2015.
PMID: 26057644
Free article.
Swedish.
No abstract available.